Originally the creation of a merger between French Bar Industries and Paradigm Medical Inc. in early 1993, the company quickly became skilled in the development, manufacturing, sales, and marketing of medical devices utilizing innovative and dependable diagnostic technologies for the early detection of glaucoma and other eye disorders.
Paradigm Medical Industries, Inc. has an exceptional history of acquiring superior medical devices and companies. In 1997 Paradigm acquired OBF Labs and the Ocular Blood Flow Analyzer (BFA). Today the BFA is the only medical device available that measures both IOP and Ocular Blood Flow, two key factors in the assessment and early treatment of glaucoma, circulatory abnormalities, and other eye maladies. In 1998 the company acquired proprietary UBM technology from Humphrey Systems. After extensive research and development Paradigm enhanced this technology to be more precise, user friendly, and detailed with its introduction of the P60 UBM, the first Windows based UBM, in early 2005. In 2000 Paradigm acquired Dicon, a manufacturer of advanced diagnostic instrumentation, and expanded its product line to include perimetry, topography, and pachymetry. Only Paradigm’s sophisticated perimeters perform testing strategies with voice recognition software, now available in 26 languages. Paradigm remains dedicated to developing or acquiring new technologies and devices that preserve the vision of tomorrow, today.
Paradigm’s expertise lies with medical devices using UBM, A-scan, B-scan, pachymetry, perimetry, ocular electrophysiology, topography, tomography, and tonometry technologies. With over 17 years of experience Paradigm specializes in providing reliable, easy-to use equipment that provide the experienced practitioner unequalled value and performance, while remaining affordable for physicians starting new practices or opening up additional satellite offices.
Paradigm Medical Industries, Inc. is a publicly owned company traded on the OTC/PK under the symbol PDMI.
Paradigm Medical Industries, Inc. use to trade on the NASDAQ under the ticker of PMED. The company recieved their delisting notification in Apr 2003 and was delisted from the NASDAQ, but maintain their patents and FDA Approved Products to trade on the OTCBB and later down where it's at now on the pink sheets under the ticker of PDMI:
The P-2000 is a light and compact A-Scan. Its portable design, with an integral printer and monitor, allow for easy and rapid mobility and set up.
A-Scan Features
•IOL Formulas: Binkhorst II, Haigis, Hoffer-Q, Holladay, SRK II, and SRK/T •Clinical Accuracy: ±0.10mm •Measuring Range: 15-39mm •Gain: 90dB with an adjustable range of 0-32dB •Measuring Method: direct contact or immersion •Measuring Mode: normal, dense cataract, aphakic, pseudophakic, or manual •Real time A-Scan display •10 MHz probe with red fixation light ensures proper patient fixation
A-Scan, Pachymetry, and intuition seamlessly combined. Our light and unique compact design includes an integral printer, built-in monitor, and foot switch. High frequency low noise probes in combination with the advanced algorithms of the P2500 allow for precision and repeatability.
A-Scan Features
•IOL Formulas: Binkhorst II, Haigis, Hoffer-Q, Holladay, SRK II, and SRK/T •Clinical Accuracy: ±0.10mm •Measuring Range: 15-39mm •Gain: 90dB with an adjustable range of 0-32dB •Measuring Method: direct contact or immersion •Measuring Mode: normal, dense cataract, aphakic, pseudophakic, or manual •Real time A-Scan display •10 MHz probe with red fixation light ensures proper patient fixation
Pachymeter Features
•Measurement range: 200-1500µm •Multiple corneal maps with graphical display •Clinical Accuracy: ±5µm •Acceptance angle: 10° •20MHz probe with a 45° angle for comfortable use •Automatic probe calibration ensures repeatable and accurate results
P2700 A/B Scan
The P-2700 is a feature rich, easy to use, and precise combination A-Scan and B-Scan. With its internal computer, fold up QWERTY keyboard, hotkeys, and integral trackball the P2700’s interface is complete and user friendly, while still allowing for easy mobility and rapid set up.
P2700 A/B Scan Features
•10 MHz A-Scan and B-Scan probes •A-Scan Gain: 98dB with an adjustable range of 0-55dB B-Scan Gain: 98dB with an adjustable range of 0-30dB •Dual or Single Display: B, B+A, B+B, A •IOL Formulas: Binkhorst II, Haigis, Hoffer-Q, Holladay, SRK-II, and SRK/T •Measuring Mode: direct contact or immersion •Individual and average results for axial length, anterior chamber depth, lens thickness, vitreous length and corneal length •Biometry Accuracy: ±0.06mm •Axial Resolution: 2mm Lateral Resolution: 0.4mm •Dynamic Replay of 5.6 seconds (56 images) •Annotation: Make notes anywhere on the screen •Portable
P37-II A/B Scan
The P37-II is a feature rich, easy to use, and precise combination A-Scan and B-Scan. No external PC is needed to operate its advanced abilities. Patient management is a breeze with the ability to save or print. No second guessing over proper probe alignment is necessary due to its distinctive audible sounds.
P37-II A/B Scan Features
•10 MHz A-Scan and B-Scan probes •A-Scan Gain: 98dB with an adjustable range of 0-55dB B-Scan Gain: 98dB with an adjustable range of 0-30dB •Dual or Single Display: B, B+A, B+B, A •IOL Formulas: Binkhorst II, Haigis, Hoffer-Q, Holladay, SRK-II, and SRK/T •Measuring Mode: direct contact or immersion •Individual and average results for axial length, anterior chamber depth, lens thickness, vitreous length and corneal length •Biometry Accuracy: ±0.06mm •8 color modes •Axial Resolution: 2mm Lateral Resolution: 0.4mm •Dynamic Replay of 5.6 seconds (56 images) •Annotation: Make notes anywhere on the screen
Paradigm’s Blood Flow Analyzer (BFA) is a tonometer that offers a fast clinically proven measurement of Ocular Blood flow (OBF), which is recognized as an important measurement in the detection and management of glaucoma and other retinal vascular disorders.
•Early glaucoma detection before loss of visual field •Greater IOP measurement accuracy than traditional Goldmann tonometers •Accurate recording of IOP, Ocular Blood flow, Pulse Amplitude, and Systolic and Diastolic cycles •Measurement of IOP and Pulsatile Ocular Blood Flow by volume, not velocity •Fast and automatic testing •Complete 5 series of tests in 10 seconds •Concise patient data print outs •The ability to measure and quantify the effectiveness of glaucoma drug treatment regimens •Identify low and normal-tension glaucoma suspects
•Measurement range: 200-1500µm •Multiple corneal maps with graphical display •Clinical Accuracy: ±5µm •Acceptance angle: 10° •20MHz probe with a 45° angle for comfortable use •Automatic probe calibration ensures repeatable and accurate results
The LD400 is an affordable 60 degree autoperimeter with voice prompt and speech recognition in 28 languages. It is capable of threshold, fast threshold and suprathreshold testing with patient fatigue reducing and interest increasing kinetic fixation.
LD400 AutoPerimeter Features •A full test suite •Voice Prompts and speech recognition in 28 languages •Kinetic fixation •Single or multiple stimulus testing •Rapid exam time
The PARAVUE 300 Corneal Topographer sets unparalleled and innovative standards for corneal topography. The basic features, ergonomic design, superior reliability and ease of use make the PARAVUE 300 the first choice in diagnostic and contact lens applications.
The SURVEYOR 500 combines the benefits of a 3D rotating Scheimpflug camera and a Placido disk, which allow for the comprehensive analysis of the entire cornea and anterior segment.
Provides the earliest detection of glaucoma through its objective 90 second long PERG test. It analyzes the functionality of ganglion cells and identifies glaucoma suspects well before perimetry can detect visual field loss. Unlike imaging techniques of the optic disk and retinal nerve fiber layer, which only provide a measure of missing ganglion cells and their axons, PARAMAX provides a measure of both missing and dysfunctional ganglion cells.
TEST Examples of Early Discovery and Diagnosis Possible • Pattern Electroretinogram (PERG)* • Glaucoma • Electroretinogram (ERG)* • Rod, cone, and retinal vascular diseases • Pigmented retinopathy • Age related maculopathy • Visual Evoked Potential (VEP)* • Amblyopia • Optic neuritis • Multiple sclerosis suspects • Electrooculogram (EOG)* • Vitelliform macular dystrophy • Electronystagmogram (ENG)* • Nystagmus • Multifocal ERG (mfERG)† • Optic nerve or retinal disease • The various dot syndromes • Multifocal PERG (mfPERG)† • Chloroquine retinopathy • Multifocal VEP (mfVEP)† • Visual field abnormalities * Available in PARAMAX and PARAMAX OMNI † Available exclusively in PARAMAX OMNI
GOOD PROCEDURES
With current imaging technologies and field perimetry, ganglion cell loss is defined, but damage has already occured
The P60 is the most universal Ultrasound BioMicroscope. It provides unprecedented image accuracy and flexibility with 12.5MHz & 20MHz probes, and 35MHz & 50MHz transducers. It offers sulcus-to-sulcus imaging, high resolution still image, live video capture, and is fully networkable.
P60 UBM Features
•Full versatility with 12.5MHz and 20MHz probes and 35MHz and 50MHz transducers •A water path attachment eliminates the need for immersion imaging •High resolution still image and live video capture •Distance Accuracy: ±0.2mm Angle Accuracy: ±3.0° Area Accuracy: ±0.1mm² •An intuitive and custom designed interface allows for a fast learning curve and easy operation •Absolute functionality in a stable Windows XP OS environment •Pseudo A-Scan accuracy of ±0.06mm •Fully networkable
p60 aCI
The P60 ACI offers many of the same features as the full P60. The option of having a 35MHz or 50MHz transducer makes the P60 ACI customizable for your Anterior imaging needs, while still being affordable.
P60 ACI Features
•Affordable Anterior imaging with the choice of either a 35MHz or 50MHz transducer •A water path attachment eliminates the need for immersion imaging •Fully networkable •Distance Accuracy: ±0.2mm Angle Accuracy: ±3.0° Area Accuracy: ±0.1mm² •An intuitive and custom designed interface allows for a fast learning curve and easy operation •Pseudo A-Scan accuracy of ±0.06mm
The PARACAM 1000 ia a compact and easy to use non-contact endothelial microscope. Paracam's advanced software algorithms- high resolution camera, and automatic image aquisition capabilities ensure a focused and accurate image.
PARACAM 1000 features
•Non-contact automatic endothelium cells analysis from seven corneal zones •Automatic sensor for L/R eye •Cells size, shape and density
•Polimegatism and pleomorphism data Currently Under FDA Review
Item # Description Item # Description 401-100-43 LD 400 additional language operating disk 408-100-23 Box of 50 tips 403-100-43 TKS additional language operating disk UMBFA-01 User Manual 401-100-88 Special Exam disk 800-200-25 Printer 405-100-54 FieldLink & FieldView Slad-01 Slit lamp adapter 405-100-52 Upgrade to latest version of FieldView 401-100-60 User Manual 800-200-35 Printer
http://findarticles.com/p/articles/mi_m0EIN/is_2002_May_21/ai_86126240/ Paradigm Medical Industries, Inc. (Nasdaq:PMED/PMEDW) announced today it has received notice of approval from the U.S. Patent Office of the Company's application for a new patent for its Photon(TM) laser delivery system.
The patent (application #09/368,737) will allow the Photon(TM) system to incorporate a special tip configuration that will allow for better and more efficient energy in the use of the laser and provide superior suction at the point of contact.
The Photon(TM) Laser System represents the first new energy source for cataract removal since the introduction of ultrasonic (acoustic shock wave), or "phaco," technology more than 30 years ago. Cataract removal surgery is the single largest volume and revenue producing outpatient surgical procedure for ophthalmologists worldwide.
PDMI reported that 25 distributors representing 30 different countries in Europe and North Africa have either contracted, or are in the process of finalizing agreements for representing the product in their respective countries.
HeadlinesFilter Headlines.•/ CORRECTION - Paradigm to Become Current With Financial Disclosure Reporting and Update on Retimax(TM) FDA Application Marketwire(Wed, Jun 9)
•Paradigm to Become Current With Financial Disclosure Reporting and Update on Retimax(TM) FDA Application Marketwire(Tue, Jun 8)
•Paradigm Announces Promotions in Management Team Marketwire(Mon, May 24)
•ARVO Meeting Yields Positive Results for Paradigm Marketwire(Thu, May 20)
•Paradigm Medical Names Charles Pritchard as Vice President of Sales and Marketing Marketwire(Wed, May 12)
•Paradigm Medical to Meet With Prospective Research Partners Marketwire(Thu, Apr 29)
•Paradigm Medical Announces Marketwire(Fri, Mar 5)
•Paradigm Medical Announces the Introduction of the Paravue 300 and Surveyor 500 at 2009 American Academy of Ophthalmology in San Francisco Marketwire(Tue, Dec 15)
•PARADIGM MEDICAL INDUSTRIES INC Financials EDGAR Online Financials(Fri, Aug 28)
•PARADIGM MEDICAL INDUSTRIES INC Files SEC form 10-Q/A, Quarterly Report EDGAR Online(Wed, Aug 5)
Template: RSI-MACD-FULLSTO-ULT-VOLUME-50MA-200MA-BB COLOR BLIND. Template: RSI-MACD-FULLSTO-ULT-VOLUME-50MA-200MA-BB COLOR BLIND. [-chart]stockcharts.com/c-sc/sc?s=pdmi&p=D&yr=0&mn=3&dy=15&i=p47868087965&a=173461334&r=537[-/chart]
TWO YEAR CHART: TWO YEAR CHART: [-chart]charting.nasdaq.com/ext/charts.dll?2-1-14-0-0-524-03NA000000pdmi-&SF:6|8|27-SH:8=200|27=10-WD=539-HT=395-[-/chart]
2 yr.,,,50-200ma,,,RSI- Volume - MACD --- green background. 2 yr.,,,50-200ma,,,RSI- Volume - MACD --- green background. [-chart]stockcharts.com/c-sc/sc?s=pdmi&p=D&yr=2&mn=0&dy=0&i=p91190925640&r=3232[-/chart]
2ma-5ma-50ma-200ma-bb with several trendlines. --- kens charting. 2ma-5ma-50ma-200ma-bb with several trendlines. --- kens charting. [-chart]stockcharts.com/c-sc/sc?chart=pdmi,uu[w,a]dhclyiay[db][pb2!b5!b50!b200!d20,2][iut!uo8!ub5!ua5,15,10!uv8!lk9!ll5!lc15!up5,5][j20444984,y]&r=3555[-/chart]
DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only.
Market Data 
Markets 
AI
